Literature DB >> 19171422

SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.

Roberta S Felix1, Gisele W B Colleoni, Otavia L Caballero, Mihoko Yamamoto, Manuella S S Almeida, Valéria C C Andrade, Maria de Lourdes L F Chauffaille, Wilson A da Silva, Maria Dirlei Begnami, Fernando Augusto Soares, Andrew J Simpson, Marco Antonio Zago, André L Vettore.   

Abstract

Serial analysis of gene expression (SAGE) allows a comprehensive profiling of gene expression within a given tissue and also an assessment of transcript abundance. We generated SAGE libraries from normal and neoplastic plasma cells to identify genes differentially expressed in multiple myeloma (MM). Normal plasma cells were obtained from palatine tonsils and MM SAGE library was generated from bone marrow plasma cells of MM patients. We obtained 29,918 SAGE tags from normal and 10,340 tags from tumor libraries. Computer-generated genomic analysis identified 46 upregulated genes in the MM library. Ten upregulated genes were selected for further investigation. Differential expression was validated by quantitative real-time PCR in purified plasma cells of 31 patients and three controls. P53CSV, DDX5, MAPKAPK2 and RANBP2 were found to be upregulated in at least 50% of the MM cases tested. All of them were also found upregulated in MM when compared to normal plasma cells in a meta-analysis using ONCOMINE microarray database. Antibodies specific to DDX5, RANBP2 and MAPKAPK2 were used in a TMA containing 57 MM cases and confirmed the expression of these proteins in 74%, 96%, and 21% of the MM samples, respectively. Analysis of differential expression using SAGE could identify genes important for myeloma tumorigenesis (P53CSV, DDX5, MAPKPK2 and RANBP2) and that could potentially be useful as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171422     DOI: 10.1016/j.canlet.2008.12.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17).

Authors:  Ralf Janknecht
Journal:  Am J Transl Res       Date:  2010-05-05       Impact factor: 4.060

Review 2.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

3.  Structural and functional analysis of the C-terminal domain of Nup358/RanBP2.

Authors:  Daniel H Lin; Stephan Zimmermann; Tobias Stuwe; Evelyn Stuwe; André Hoelz
Journal:  J Mol Biol       Date:  2013-01-23       Impact factor: 5.469

Review 4.  Proteolytic Control of Lipid Metabolism.

Authors:  Pingdewinde N Sam; Erica Avery; Steven M Claypool
Journal:  ACS Chem Biol       Date:  2019-09-30       Impact factor: 5.100

5.  Crystal structure of the N-terminal domain of Nup358/RanBP2.

Authors:  Susanne A Kassube; Tobias Stuwe; Daniel H Lin; C Danielle Antonuk; Johanna Napetschnig; Günter Blobel; André Hoelz
Journal:  J Mol Biol       Date:  2012-09-07       Impact factor: 5.469

6.  High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.

Authors:  Jiayi Zhang; Rong Cong; Kai Zhao; Yi Wang; Ninghong Song; Min Gu
Journal:  Ann Transl Med       Date:  2019-07

7.  hSAGEing: an improved SAGE-based software for identification of human tissue-specific or common tumor markers and suppressors.

Authors:  Cheng-Hong Yang; Li-Yeh Chuang; Tsung-Mu Shih; Hsueh-Wei Chang
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

8.  In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis.

Authors:  Alan A Dombkowski; Zakia Sultana; Douglas B Craig; Hasan Jamil
Journal:  Cancer Inform       Date:  2011-02-17

9.  Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity.

Authors:  Reha Yildirimman; Gabriella Brolén; Mireia Vilardell; Gustav Eriksson; Jane Synnergren; Hans Gmuender; Atanas Kamburov; Magnus Ingelman-Sundberg; José Castell; Agustin Lahoz; Jos Kleinjans; Joost van Delft; Petter Björquist; Ralf Herwig
Journal:  Toxicol Sci       Date:  2011-08-27       Impact factor: 4.849

10.  FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.

Authors:  Walter Moises Tobias Braga; Bruna Raphaeli da Silva; Ana Carolina de Carvalho; Yumi H Maekawa; Adriana Bruscato Bortoluzzo; Edgar Gil Rizzatti; Djordje Atanackovic; Gisele Wally Braga Colleoni
Journal:  Cancer Immunol Immunother       Date:  2014-08-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.